-
Something wrong with this record ?
The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential tumorigenic activity
F. Šenigl, AI. Soikkeli, S. Prost, DG. Schatz, M. Slavková, J. Hejnar, J. Alinikula
Language English Country Netherlands
Document type Journal Article
NLK
Directory of Open Access Journals
from 2021
PubMed Central
from 2021
ROAD: Directory of Open Access Scholarly Resources
from 2021
- MeSH
- AICDA (Activation-Induced Cytidine Deaminase) MeSH
- Antigens, Polyomavirus Transforming genetics metabolism MeSH
- Antigens, Viral, Tumor genetics metabolism MeSH
- B-Lymphocytes virology metabolism immunology MeSH
- Cell Line MeSH
- Cytidine Deaminase * genetics metabolism MeSH
- Tumor Virus Infections genetics virology MeSH
- Carcinogenesis genetics MeSH
- Humans MeSH
- Mutation MeSH
- Simian virus 40 * genetics MeSH
- Polyomavirus Infections genetics virology MeSH
- Somatic Hypermutation, Immunoglobulin genetics MeSH
- Enhancer Elements, Genetic * genetics MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Simian virus 40 (SV40) is a monkey virus with tumorigenic potential in rodents and is associated with several types of human cancers, including lymphomas. A related Merkel cell polyomavirus causes carcinoma in humans by expressing truncated large tumor antigen (LT), with truncations caused by APOBEC family of cytidine deaminase-induced mutations. AID (activation-induced cytidine deaminase), a member of the APOBEC family, is the initiator of the antibody diversification process known as somatic hypermutation and its aberrant expression and targeting is a frequent source of lymphomagenesis. In this study, we investigated whether AID could cause mutations in SV40 LT. We demonstrate that the SV40 enhancer has strong somatic hypermutation targeting activity in several cell types and that AID-induced mutations accumulate in SV40 LT in B cells and kidney cells and cause truncated LT expression in B cells. Our results argue that the ability of the SV40 enhancer to target somatic hypermutation to LT is a potential source of LT truncation events that could contribute to tumorigenesis in various cell types, thereby linking SV40 infection with malignant development through a novel mutagenic pathway.
Department of Immunobiology Yale School of Medicine New Haven CT 06520 8011 USA
Institute of Biomedicine University of Turku Turku 20520 Finland
Turku Doctoral Programme of Molecular Medicine University of Turku Turku Finland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003178
- 003
- CZ-PrNML
- 005
- 20250411093647.0
- 007
- ta
- 008
- 250121e20241028ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.tvr.2024.200293 $2 doi
- 035 __
- $a (PubMed)39490533
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Šenigl, Filip $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, 14220, Czech Republic. Electronic address: filip.senigl@img.cas.cz
- 245 14
- $a The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential tumorigenic activity / $c F. Šenigl, AI. Soikkeli, S. Prost, DG. Schatz, M. Slavková, J. Hejnar, J. Alinikula
- 520 9_
- $a Simian virus 40 (SV40) is a monkey virus with tumorigenic potential in rodents and is associated with several types of human cancers, including lymphomas. A related Merkel cell polyomavirus causes carcinoma in humans by expressing truncated large tumor antigen (LT), with truncations caused by APOBEC family of cytidine deaminase-induced mutations. AID (activation-induced cytidine deaminase), a member of the APOBEC family, is the initiator of the antibody diversification process known as somatic hypermutation and its aberrant expression and targeting is a frequent source of lymphomagenesis. In this study, we investigated whether AID could cause mutations in SV40 LT. We demonstrate that the SV40 enhancer has strong somatic hypermutation targeting activity in several cell types and that AID-induced mutations accumulate in SV40 LT in B cells and kidney cells and cause truncated LT expression in B cells. Our results argue that the ability of the SV40 enhancer to target somatic hypermutation to LT is a potential source of LT truncation events that could contribute to tumorigenesis in various cell types, thereby linking SV40 infection with malignant development through a novel mutagenic pathway.
- 650 12
- $a opičí virus SV40 $x genetika $7 D013539
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a zesilovače transkripce $x genetika $7 D004742
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a cytidindeaminasa $x genetika $x metabolismus $7 D003564
- 650 _2
- $a B-lymfocyty $x virologie $x metabolismus $x imunologie $7 D001402
- 650 _2
- $a somatická hypermutace imunoglobulinových genů $x genetika $7 D027041
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a antigeny virové nádorové $x genetika $x metabolismus $7 D000957
- 650 _2
- $a karcinogeneze $x genetika $7 D063646
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a infekce onkogenními viry $x genetika $x virologie $7 D014412
- 650 _2
- $a polyomavirové infekce $x genetika $x virologie $7 D027601
- 650 _2
- $a antigeny transformující polyomavirové $x genetika $x metabolismus $7 D000952
- 650 _7
- $a AICDA (aktivací indukovaná cytidindeamináza) $2 czmesh $7 D000098830
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Soikkeli, Anni I $u Institute of Biomedicine, University of Turku, Turku, 20520, Finland; Turku Doctoral Programme of Molecular Medicine, University of Turku, Turku, Finland
- 700 1_
- $a Prost, Salomé $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, 14220, Czech Republic
- 700 1_
- $a Schatz, David G $u Department of Immunobiology, Yale School of Medicine, New Haven.CT, 06520-8011, USA
- 700 1_
- $a Slavková, Martina $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, 14220, Czech Republic
- 700 1_
- $a Hejnar, Jiří $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, 14220, Czech Republic
- 700 1_
- $a Alinikula, Jukka $u Institute of Biomedicine, University of Turku, Turku, 20520, Finland. Electronic address: jukka.alinikula@utu.fi
- 773 0_
- $w MED00216054 $t Tumour virus research $x 2666-6790 $g Roč. 18 (20241028), s. 200293
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39490533 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250411093639 $b ABA008
- 999 __
- $a ok $b bmc $g 2263120 $s 1239185
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 18 $c - $d 200293 $e 20241028 $i 2666-6790 $m Tumour virus research $n Tumour Virus Res $x MED00216054
- LZP __
- $a Pubmed-20250121